13F HOLDINGS REPORT
GREAT POINT PARTNERS LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001814554-25-000164
Total Value
$242.5M
Positions
30
Other Managers
2
Confidential Omitted
No
Holdings (30)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AMYLYX PHARMACEUTICALS INC | AMLX | 1,700,000 | $23.1M | 9.53% |
| 2 | REZOLUTE INC COM NEW | RZLT | 2,451,809 | $23.0M | 9.50% |
| 3 | NEKTAR THERAPEUTICS COM NEW | NKTR | 300,000 | $17.1M | 7.04% |
| 4 | ZURA BIO LTD CLASS A ORD SHS | ZURA | 3,815,930 | $16.5M | 6.81% |
| 5 | SOLENO THERAPEUTICS INC | SLNO | 225,000 | $15.2M | 6.27% |
| 6 | ASCENDIS PHARMA A/S SPONSORED ADR | ASND | 75,000 | $14.9M | 6.15% |
| 7 | ABIVAX SA SPONSORED ADS | AAVXF | 150,000 | $12.7M | 5.25% |
| 8 | APOGEE THERAPEUTICS INC | APGE | 304,000 | $12.1M | 4.98% |
| 9 | DIANTHUS THERAPEUTICS INC | DNTH | 265,803 | $10.5M | 4.31% |
| 10 | CYTOKINETICS INC COM NEW | CYTK | 150,000 | $8.2M | 3.40% |
| 11 | IMMUNOVANT INC | IMVT | 500,000 | $8.1M | 3.32% |
| 12 | XENON PHARMACEUTICALS INC | XENE | 200,000 | $8.0M | 3.31% |
| 13 | NEUROGENE INC | NGNE | 446,814 | $7.7M | 3.19% |
| 14 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 1,200,000 | $7.1M | 2.92% |
| 15 | UPSTREAM BIO INC | UPB | 300,000 | $5.6M | 2.33% |
| 16 | JADE BIOSCIENCES INC COM NEW | JBIO | 632,599 | $5.5M | 2.25% |
| 17 | IONIS PHARMACEUTICALS INC | IONS | 80,000 | $5.2M | 2.16% |
| 18 | AKERO THERAPEUTICS INC | 00973Y108 | 103,848 | $4.9M | 2.03% |
| 19 | TAYSHA GENE THERAPIES INC COM SHS | TSHA | 1,500,000 | $4.9M | 2.02% |
| 20 | CONTEXT THERAPEUTICS INC | CNTX | 4,683,711 | $4.5M | 1.87% |
| 21 | PHARVARIS N V | PHVS | 155,105 | $3.9M | 1.60% |
| 22 | DBV TECHNOLOGIES S A SPONSORED ADS | DBVTF | 378,594 | $3.8M | 1.56% |
| 23 | LEGEND BIOTECH CORP SPONSORED ADS | LEGN | 113,460 | $3.7M | 1.53% |
| 24 | ORUKA THERAPEUTICS INC | ORKA | 183,330 | $3.5M | 1.45% |
| 25 | UNICYCIVE THERAPEUTICS INC COM NEW | UNCY | 796,558 | $3.5M | 1.43% |
| 26 | SANA BIOTECHNOLOGY INC | SANA | 700,000 | $2.5M | 1.02% |
| 27 | ABSCI CORPORATION | ABSI | 796,438 | $2.4M | 1.00% |
| 28 | HRMY 10/17/2025 40 Call | HRMY | 85,000 | $2.3M | 0.97% |
| 29 | PLIANT THERAPEUTICS INC | PLRX | 850,000 | $1.3M | 0.52% |
| 30 | CAPR 12/19/2025 7.5 Put | CAPR | 87,700 | $632,317 | 0.26% |